Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog… bySrinathJanuary 22, 2022
